C07D 309/10
Oxygen atoms
C07D309/10 (Oxygen atoms) appears on 1,677 US grants and 924 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,677
- Published applications
- 924
- Assignees
- 621
- Inventors
- 3,654
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 83 | 0 |
| 1977 | 79 | 0 |
| 1978 | 164 | 0 |
| 1979 | 57 | 0 |
| 1980 | 65 | 0 |
| 1981 | 52 | 0 |
| 1982 | 44 | 0 |
| 1983 | 40 | 0 |
| 1984 | 39 | 0 |
| 1985 | 21 | 0 |
| 1986 | 16 | 0 |
| 1987 | 16 | 0 |
| 1988 | 19 | 0 |
| 1989 | 23 | 0 |
| 1990 | 22 | 0 |
| 1991 | 15 | 0 |
| 1992 | 21 | 0 |
| 1993 | 26 | 0 |
| 1994 | 32 | 0 |
| 1995 | 28 | 0 |
| 1996 | 22 | 0 |
| 1997 | 35 | 0 |
| 1998 | 31 | 0 |
| 1999 | 16 | 0 |
| 2000 | 16 | 0 |
| 2001 | 22 | 6 |
| 2002 | 30 | 27 |
| 2003 | 22 | 28 |
| 2004 | 19 | 38 |
| 2005 | 14 | 39 |
| 2006 | 15 | 33 |
| 2007 | 10 | 28 |
| 2008 | 23 | 34 |
| 2009 | 32 | 46 |
| 2010 | 28 | 34 |
| 2011 | 29 | 42 |
| 2012 | 23 | 42 |
| 2013 | 32 | 50 |
| 2014 | 37 | 49 |
| 2015 | 59 | 53 |
| 2016 | 35 | 48 |
| 2017 | 50 | 39 |
| 2018 | 25 | 32 |
| 2019 | 39 | 42 |
| 2020 | 32 | 43 |
| 2021 | 33 | 42 |
| 2022 | 23 | 31 |
| 2023 | 18 | 34 |
| 2024 | 13 | 26 |
| 2025 | 16 | 22 |
| 2026 | 16 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Salts of neuroceuticals and uses thereof25 Aug 2026US 12,714,711 B2SyneuRx International (Taiwan) Corp.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Phenyl-sulfamoyl-benzoic acid derivatives as ERAP1-modulators28 Jul 2026US 12,692,223 B2Grey Wolf Therapeutics Limited
- Griseofulvin compound and pharmaceutical use thereof28 Jul 2026US 12,692,258 B2Daiichi Sankyo Company, Limited
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Usp30 inhibitors and uses thereof1 Oct 2026US 2026/0297026 A1Vincere Biosciences, Inc.
- Crystalline complexes between velagliflozin and selected co-crystal forming agents, methods for their preparation and the use thereof for preparing medicaments24 Sep 2026US 2026/0285825 A1Boehringer Ingelheim Vetmedica GmbH
- Endocannabinoid ligands and related analogs13 Aug 2026US 2026/0234099 A1Northeastern University
- Isotopologues of aminoheteroaryl kinase inhibitors and uses thereof13 Aug 2026US 2026/0234111 A1Allorion Therapeutics Inc
- Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, pattern forming method, and method for producing electronic device9 Jul 2026US 2026/0194813 A1FUJIFILM Corporation
Most cited
By later US patents
- Poly(carbonates)176US 4,079,038 AAlza Corporation · 1978
- Phenethanolamine derivatives172US 4,992,474 AGlaxo Group Limited · 1991
- Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture142US 7,579,449 B2Boehringer Ingelheim International GmbH · 2009
- Composition and process140US 4,306,075 AThe Upjohn Company · 1981
- Antiretroviral enantiomeric nucleotide analogs124US 6,057,305 AInstitute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic · 2000